Evidence map›Paper›PMID 35288807›Full record

ArticleEuropean journal of hybrid imaging2022

Clinical experience with

Irina Vierasu, Nicola Trotta, Simone Albisinni, Céline Mathey, Gil Leurquin-Sterk, Simon Lacroix, Gaetan Van Simaeys, Thierry Quackels, Thierry Roumeguère, Serge Goldman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hybrid imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Comparison of Digital versus AnalogDiagnostics (Basel, Switzerland) · 2023
    Article
  2. European journal of hybrid imaging · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Irina VierasuNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. Ortansa-Irina.Vierasu@erasme.ulb.ac.be.ORCID http://orcid.org/0000-0002-0640-0916
Nicola TrottaNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Simone AlbisinniUrology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Céline MatheyNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Gil Leurquin-SterkNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Simon LacroixNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Gaetan Van SimaeysNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Thierry QuackelsUrology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Thierry RoumeguèreUrology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Serge GoldmanNuclear Medicine Department and PET/Biomedical Cyclotron Unit, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigital PET/CT systems make use of a new technology with higher sensitivity and other better technological features than the analog ones. They require adaptation of the trade-off between performance, tracer dose and acquisition time. The aim of the study was to explore the performance of

methodsA total of 54 PCa patients experiencing biochemical recurrence were included in the study, in which we analysed the diagnostic performance of digital

resultsWe detected overall

conclusion

Indexed as

18F-JK-PSMA-7 PET/CTBiochemical recurrenceDetection rateProstate cancer

Identifiers

PMID35288807
PMCPMC8921393
OpenAlexW4220881572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.